The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HER2 Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global HER2 Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global HER2 Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global HER2 Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global HER2 Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global HER2 Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global HER2 Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HER2 Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HER2 Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc. and Leica Biosystems (Danaher Corporation), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
HER2 Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Breast Cancer
Stomach Cancer
Market segment by Application
Hospital
Diagnostic Laboratory
Other
Market segment by players, this report covers
Abbott
Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Leica Biosystems (Danaher Corporation)
Empire Genomics, Inc. (Biocare Medical,LLC)
Bio-Genex Laboratories
Abnova Corporation
Oxford Gene Technology IP Limited(Sysmex Corporation)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe HER2 Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of HER2 Testing, with revenue, gross margin and global market share of HER2 Testing from 2018 to 2023.
Chapter 3, the HER2 Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and HER2 Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of HER2 Testing.
Chapter 13, to describe HER2 Testing research findings and conclusion.
The global HER2 Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global HER2 Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global HER2 Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global HER2 Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global HER2 Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global HER2 Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HER2 Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HER2 Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc. and Leica Biosystems (Danaher Corporation), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
HER2 Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Breast Cancer
Stomach Cancer
Market segment by Application
Hospital
Diagnostic Laboratory
Other
Market segment by players, this report covers
Abbott
Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Leica Biosystems (Danaher Corporation)
Empire Genomics, Inc. (Biocare Medical,LLC)
Bio-Genex Laboratories
Abnova Corporation
Oxford Gene Technology IP Limited(Sysmex Corporation)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe HER2 Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of HER2 Testing, with revenue, gross margin and global market share of HER2 Testing from 2018 to 2023.
Chapter 3, the HER2 Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and HER2 Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of HER2 Testing.
Chapter 13, to describe HER2 Testing research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of HER2 Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of HER2 Testing by Type
1.3.1 Overview: Global HER2 Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global HER2 Testing Consumption Value Market Share by Type in 2022
1.3.3 Breast Cancer
1.3.4 Stomach Cancer
1.4 Global HER2 Testing Market by Application
1.4.1 Overview: Global HER2 Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Diagnostic Laboratory
1.4.4 Other
1.5 Global HER2 Testing Market Size & Forecast
1.6 Global HER2 Testing Market Size and Forecast by Region
1.6.1 Global HER2 Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global HER2 Testing Market Size by Region, (2018-2029)
1.6.3 North America HER2 Testing Market Size and Prospect (2018-2029)
1.6.4 Europe HER2 Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific HER2 Testing Market Size and Prospect (2018-2029)
1.6.6 South America HER2 Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa HER2 Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott HER2 Testing Product and Solutions
2.1.4 Abbott HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Hoffmann-La Roche Ltd
2.2.1 Hoffmann-La Roche Ltd Details
2.2.2 Hoffmann-La Roche Ltd Major Business
2.2.3 Hoffmann-La Roche Ltd HER2 Testing Product and Solutions
2.2.4 Hoffmann-La Roche Ltd HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.3 Agilent Technologies, Inc.
2.3.1 Agilent Technologies, Inc. Details
2.3.2 Agilent Technologies, Inc. Major Business
2.3.3 Agilent Technologies, Inc. HER2 Testing Product and Solutions
2.3.4 Agilent Technologies, Inc. HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.4 Thermo Fisher Scientific, Inc.
2.4.1 Thermo Fisher Scientific, Inc. Details
2.4.2 Thermo Fisher Scientific, Inc. Major Business
2.4.3 Thermo Fisher Scientific, Inc. HER2 Testing Product and Solutions
2.4.4 Thermo Fisher Scientific, Inc. HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.5 Leica Biosystems (Danaher Corporation)
2.5.1 Leica Biosystems (Danaher Corporation) Details
2.5.2 Leica Biosystems (Danaher Corporation) Major Business
2.5.3 Leica Biosystems (Danaher Corporation) HER2 Testing Product and Solutions
2.5.4 Leica Biosystems (Danaher Corporation) HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Leica Biosystems (Danaher Corporation) Recent Developments and Future Plans
2.6 Empire Genomics, Inc. (Biocare Medical,LLC)
2.6.1 Empire Genomics, Inc. (Biocare Medical,LLC) Details
2.6.2 Empire Genomics, Inc. (Biocare Medical,LLC) Major Business
2.6.3 Empire Genomics, Inc. (Biocare Medical,LLC) HER2 Testing Product and Solutions
2.6.4 Empire Genomics, Inc. (Biocare Medical,LLC) HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Empire Genomics, Inc. (Biocare Medical,LLC) Recent Developments and Future Plans
2.7 Bio-Genex Laboratories
2.7.1 Bio-Genex Laboratories Details
2.7.2 Bio-Genex Laboratories Major Business
2.7.3 Bio-Genex Laboratories HER2 Testing Product and Solutions
2.7.4 Bio-Genex Laboratories HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Genex Laboratories Recent Developments and Future Plans
2.8 Abnova Corporation
2.8.1 Abnova Corporation Details
2.8.2 Abnova Corporation Major Business
2.8.3 Abnova Corporation HER2 Testing Product and Solutions
2.8.4 Abnova Corporation HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abnova Corporation Recent Developments and Future Plans
2.9 Oxford Gene Technology IP Limited(Sysmex Corporation)
2.9.1 Oxford Gene Technology IP Limited(Sysmex Corporation) Details
2.9.2 Oxford Gene Technology IP Limited(Sysmex Corporation) Major Business
2.9.3 Oxford Gene Technology IP Limited(Sysmex Corporation) HER2 Testing Product and Solutions
2.9.4 Oxford Gene Technology IP Limited(Sysmex Corporation) HER2 Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Oxford Gene Technology IP Limited(Sysmex Corporation) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global HER2 Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of HER2 Testing by Company Revenue
3.2.2 Top 3 HER2 Testing Players Market Share in 2022
3.2.3 Top 6 HER2 Testing Players Market Share in 2022
3.3 HER2 Testing Market: Overall Company Footprint Analysis
3.3.1 HER2 Testing Market: Region Footprint
3.3.2 HER2 Testing Market: Company Product Type Footprint
3.3.3 HER2 Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global HER2 Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global HER2 Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global HER2 Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global HER2 Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America HER2 Testing Consumption Value by Type (2018-2029)
6.2 North America HER2 Testing Consumption Value by Application (2018-2029)
6.3 North America HER2 Testing Market Size by Country
6.3.1 North America HER2 Testing Consumption Value by Country (2018-2029)
6.3.2 United States HER2 Testing Market Size and Forecast (2018-2029)
6.3.3 Canada HER2 Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico HER2 Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe HER2 Testing Consumption Value by Type (2018-2029)
7.2 Europe HER2 Testing Consumption Value by Application (2018-2029)
7.3 Europe HER2 Testing Market Size by Country
7.3.1 Europe HER2 Testing Consumption Value by Country (2018-2029)
7.3.2 Germany HER2 Testing Market Size and Forecast (2018-2029)
7.3.3 France HER2 Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom HER2 Testing Market Size and Forecast (2018-2029)
7.3.5 Russia HER2 Testing Market Size and Forecast (2018-2029)
7.3.6 Italy HER2 Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific HER2 Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific HER2 Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific HER2 Testing Market Size by Region
8.3.1 Asia-Pacific HER2 Testing Consumption Value by Region (2018-2029)
8.3.2 China HER2 Testing Market Size and Forecast (2018-2029)
8.3.3 Japan HER2 Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea HER2 Testing Market Size and Forecast (2018-2029)
8.3.5 India HER2 Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia HER2 Testing Market Size and Forecast (2018-2029)
8.3.7 Australia HER2 Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America HER2 Testing Consumption Value by Type (2018-2029)
9.2 South America HER2 Testing Consumption Value by Application (2018-2029)
9.3 South America HER2 Testing Market Size by Country
9.3.1 South America HER2 Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil HER2 Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina HER2 Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa HER2 Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa HER2 Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa HER2 Testing Market Size by Country
10.3.1 Middle East & Africa HER2 Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey HER2 Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia HER2 Testing Market Size and Forecast (2018-2029)
10.3.4 UAE HER2 Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 HER2 Testing Market Drivers
11.2 HER2 Testing Market Restraints
11.3 HER2 Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 HER2 Testing Industry Chain
12.2 HER2 Testing Upstream Analysis
12.3 HER2 Testing Midstream Analysis
12.4 HER2 Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
